CORE PHARMACEUTICALS LIMITEDActive
Key figures
Like most small UK companies, CORE PHARMACEUTICALS LIMITED does not publish a profit and loss account in its latest accounts. The figures below come from the balance sheet.
Ratios
2023/24Balance sheet structure
Filed accounts2020/21–2023/24
| 2020/21 | 2021/22 | 2022/23 | 2023/24 | |
|---|---|---|---|---|
| Cash at bank and in hand | 190 | 160 | 4,068 | 3,923 |
| Total assets | — | 3,160 | 5,511 | 132,368 |
| Total liabilities | 220 | 1,456 | 30,274 | — |
| Net assets / total equity | -30 | 1,704 | -15,159 | -65,886 |
| Average number of employees | 1 | 1 | 1 | 2 |
A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.
Summary: CORE PHARMACEUTICALS LIMITED
Company
CORE PHARMACEUTICALS LIMITED is a private limited company registered with Companies House under company number 12792227. It was incorporated on 4 Aug 2020. Its status is active. The registered office is in St helens (WA9). Its nature of business (SIC 2007) is wholesale of pharmaceutical goods (46460).
Accounts
The latest accounts in the database are for 2023/24 (period ending 31 Jul 2024); the company files audit-exempt subsidiary. Net assets were −£65,886, down 334.6% on the previous year. Cash at bank and in hand was £3,923. The company had an average of 2 employees. Figures are available for 4 financial years (2020/21–2023/24).
Control and charges
One person with significant control is registered.
Filing deadlines
The next accounts are due by 31 Dec 2026. The next confirmation statement is due by 25 Apr 2027.